137 related articles for article (PubMed ID: 18472901)
1. Synthesis, Characterization and Solution Chemistry of trans-Indazoliumtetrachlorobis(Indazole)Ruthenate(III), a New Anticancer Ruthenium Complex. IR, UV, NMR, HPLC Investigations and Antitumor Activity. Crystal Structures of trans-1-Methyl-Indazoliumtetrachlorobis-(1-Methylindazole)Ruthenate(III) and its Hydrolysis Product trans-Monoaquatrichlorobis-(1-Methylindazole)-Ruthenate(III).
Lipponer KG; Vogel E; Keppler BK
Met Based Drugs; 1996; 3(5):243-60. PubMed ID: 18472901
[TBL] [Abstract][Full Text] [Related]
2. Solvolysis of the Tumor-Inhibiting Ru(III)-Complex trans-Tetrachlorobis(Indazole)Ruthenate(III).
Pieper T; Peti W; Keppler BK
Met Based Drugs; 2000; 7(4):225-32. PubMed ID: 18475949
[TBL] [Abstract][Full Text] [Related]
3. Tuning of redox potentials for the design of ruthenium anticancer drugs -- an electrochemical study of [trans-RuCl(4)L(DMSO)](-) and [trans-RuCl(4)L(2)](-) complexes, where L = imidazole, 1,2,4-triazole, indazole.
Reisner E; Arion VB; Guedes da Silva MF; Lichtenecker R; Eichinger A; Keppler BK; Kukushkin VY; Pombeiro AJ
Inorg Chem; 2004 Nov; 43(22):7083-93. PubMed ID: 15500346
[TBL] [Abstract][Full Text] [Related]
4. Hydrolysis of the tumor-inhibiting ruthenium(III) complexes HIm trans-[RuCl4(im)2] and HInd trans-[RuCl4(ind)2] investigated by means of HPCE and HPLC-MS.
Küng A; Pieper T; Wissiack R; Rosenberg E; Keppler BK
J Biol Inorg Chem; 2001 Mar; 6(3):292-9. PubMed ID: 11315565
[TBL] [Abstract][Full Text] [Related]
5. Reactions of potent antitumor complex trans-[Ru(III)Cl4(indazole)2]- with a DNA-relevant nucleobase and thioethers: insight into biological action.
Egger A; Arion VB; Reisner E; Cebrián-Losantos B; Shova S; Trettenhahn G; Keppler BK
Inorg Chem; 2005 Jan; 44(1):122-32. PubMed ID: 15627368
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structural, spectroscopic, and electrochemical characterization of new ruthenium dimethyl sulfoxide nitrosyls.
Serli B; Zangrando E; Iengo E; Mestroni G; Yellowlees L; Alessio E
Inorg Chem; 2002 Jul; 41(15):4033-43. PubMed ID: 12132931
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and reactivity of the aquation product of the antitumor complex trans-[Ru(III)Cl4(indazole)2]-.
Cebrián-Losantos B; Reisner E; Kowol CR; Roller A; Shova S; Arion VB; Keppler BK
Inorg Chem; 2008 Jul; 47(14):6513-23. PubMed ID: 18553904
[TBL] [Abstract][Full Text] [Related]
8. Syntheses and Crystal Structures of Ruthenium Complexes of 1,4,8,11-Tetraazacyclotetradecane, Tris(2-aminoethyl)amine (tren), and Bis(2-aminoethyl)(iminomethyl)amine. A Microporous Layered Structure Consisting of {[K(tren)](2)[RuCl(6)]}(n)()(n)()(-) and {(H(5)O(2))(4)[RuCl(6)]}(n)()(n)()(+).
Sakai K; Yamada Y; Tsubomura T
Inorg Chem; 1996 May; 35(11):3163-3172. PubMed ID: 11666513
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships for NAMI-A-type complexes (HL)[trans-RuCl4L(S-dmso)ruthenate(III)] (L = imidazole, indazole, 1,2,4-triazole, 4-amino-1,2,4-triazole, and 1-methyl-1,2,4-triazole): aquation, redox properties, protein binding, and antiproliferative activity.
Groessl M; Reisner E; Hartinger CG; Eichinger R; Semenova O; Timerbaev AR; Jakupec MA; Arion VB; Keppler BK
J Med Chem; 2007 May; 50(9):2185-93. PubMed ID: 17402720
[TBL] [Abstract][Full Text] [Related]
10. The Interaction of the Antitumor Complexes Na[trans-RuCl(4) (DMSO)(Im)] and Na[trans-RuCl(4)(DMSO)(Ind)] With Apotransferrin: a Spectroscopic Study.
Messori L; Kratz F; Alessio E
Met Based Drugs; 1996; 3(1):1-9. PubMed ID: 18472787
[TBL] [Abstract][Full Text] [Related]
11. Isomeric [RuCl2(dmso)2(indazole)2] complexes: ruthenium(II)-mediated coupling reaction of acetonitrile with 1H-indazole.
Reisner E; Arion VB; Rufińska A; Chiorescu I; Schmid WF; Keppler BK
Dalton Trans; 2005 Jul; (14):2355-64. PubMed ID: 15995743
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo biological activity screening of Ru(III) complexes involving 6-benzylaminopurine derivatives with higher pro-apoptotic activity than NAMI-A.
Trávníček Z; Matiková-Mal'arová M; Novotná R; Vančo J; Stěpánková K; Suchý P
J Inorg Biochem; 2011 Jul; 105(7):937-48. PubMed ID: 21536006
[TBL] [Abstract][Full Text] [Related]
13. The hydrolysis mechanism of the anticancer ruthenium drugs NAMI-A and ICR investigated by DFT-PCM calculations.
Vargiu AV; Robertazzi A; Magistrato A; Ruggerone P; Carloni P
J Phys Chem B; 2008 Apr; 112(14):4401-9. PubMed ID: 18348562
[TBL] [Abstract][Full Text] [Related]
14. Molecular structure, solution chemistry and biological properties of the novel [ImH][trans-IrCl(4)(Im)(DMSO)], (I) and of the orange form of [(DMSO)(2)H][trans-IrCl(4)(DMSO)(2)], (II), complexes.
Messori L; Marcon G; Orioli P; Fontani M; Zanello P; Bergamo A; Sava G; Mura P
J Inorg Biochem; 2003 May; 95(1):37-46. PubMed ID: 12706540
[TBL] [Abstract][Full Text] [Related]
15. Stereochemically Controlled Synthesis of Ruthenium(II) Complexes Containing Bis(oxazolin-2'-yl)pyridine Ligands. X-ray Crystal Structures of trans-[RuCl(2)(PPh(3)){kappa(3)-N,N,N-(S,S)-(i)Pr-pybox}] and [RuCl(=C=C=CPh(2))(PPh(3)){kappa(3)-N,N,N-(S,S)-(i)Pr-pybox}][PF(6)] ((S,S)-(i)Pr-pybox= 2,6-Bis[4'-(S)-isopropyloxazolin-2'-yl]pyridine).
Cadierno V; Gamasa MP; Gimeno J; Iglesias L; García-Granda S
Inorg Chem; 1999 Jun; 38(12):2874-2879. PubMed ID: 11671033
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, Structure, and Reactivity of [RuCl(PP)L]PF(6) (PP = (PPh(3))(2), Ph(2)P(CH(2))(4)PPh(2); L = P(py)(3), PPh(py)(2), py = 2-pyridyl). The "Missing" P,N,N'-Coordination Mode for 2-Pyridylphosphines.
Schutte RP; Rettig SJ; Joshi AM; James BR
Inorg Chem; 1997 Dec; 36(25):5809-5817. PubMed ID: 11670203
[TBL] [Abstract][Full Text] [Related]
17. Syntheses, characterization and X-ray structures of the fac-[RuCl3(NO)(dppe)] and the trans-[RuCl(NO)(dppe)2]2+ species.
Zampieri RC; Von Poelhsitz G; Batista AA; Nascimento OR; Ellena J; Castellano EE
J Inorg Biochem; 2002 Sep; 92(1):82-8. PubMed ID: 12230991
[TBL] [Abstract][Full Text] [Related]
18. Metallacycles of porphyrins as building blocks in the construction of higher order assemblies through axial coordination of bridging ligands: solution- and solid-state characterization of molecular sandwiches and molecular wires.
Iengo E; Zangrando E; Minatel R; Alessio E
J Am Chem Soc; 2002 Feb; 124(6):1003-13. PubMed ID: 11829609
[TBL] [Abstract][Full Text] [Related]
19. Electronic structural investigations of ruthenium compounds and anticancer prodrugs.
Harris TV; Szilagyi RK; McFarlane Holman KL
J Biol Inorg Chem; 2009 Aug; 14(6):891-8. PubMed ID: 19350289
[TBL] [Abstract][Full Text] [Related]
20. NO Releasing and Anticancer Properties of Octahedral Ruthenium-Nitrosyl Complexes with Equatorial 1 H-Indazole Ligands.
Orlowska E; Babak MV; Dömötör O; Enyedy EA; Rapta P; Zalibera M; Bučinský L; Malček M; Govind C; Karunakaran V; Farid YCS; McDonnell TE; Luneau D; Schaniel D; Ang WH; Arion VB
Inorg Chem; 2018 Sep; 57(17):10702-10717. PubMed ID: 30106571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
